2025-2034 Autotransfusion Devices Market Roadmap: Insights for Competitive Advantage

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Autotransfusion Devices Market Size By 2025?
The market size for autotransfusion devices has seen significant growth in the past years. There will be a growth from 1.21 billion dollars in 2024 to 1.27 billion dollars in 2025, representing a compound annual growth rate (CAGR) of 5.2%. The growth throughout the history can be credited to factors such as an uptick in surgical procedures, the frequency of cardiovascular disease, orthopedic surgeries and joint replacements, emphasis on patient safety, along with attempts to minimize the costs of blood transfusion.

How Big Is the Autotransfusion Devices Market Size Expected to Grow by 2029?
In the coming years, the market size for autotransfusion devices is projected to experience significant growth, expanding to a sum of $1.67 billion in 2029, representing a 7.0% compound annual growth rate (CAGR). Factors contributing to this growth in the forecast period include an increasing elderly population, the spread of ambulatory surgical centers, a growing emphasis on blood conservation in the field of obstetrics, and implementation in budding healthcare markets. Key trends anticipated in the forecast period encompass advancements in blood processing technology, the incorporation of superior sensors, tailoring for a variety of procedures, closed-loop systems exclusive to single-donors, and the reduction in device sizes.

View the full report here:
https://www.thebusinessresearchcompany.com/report/autotransfusion-devices-global-market-report

Which Key Market Drivers Powering Autotransfusion Devices Market Expansion and Growth?
The escalating incidence of cardiovascular diseases is set to fuel the expansion of the autotransfusion device market. Cardiovascular diseases, or CVDs, are health conditions that involve the heart or blood vessels. Autotransfusion devices are instrumental in reducing the reliance on allogeneic blood transfusions, which utilize blood donated from external sources. Autotransfusion, on the other hand, reinfuses the patient's own blood, decreasing the likelihood of reactions or complications arising from donor blood. For example, the Heart Disease and Stroke Statistics-2022 Update report by the American Heart Association, a US-based non-profit organization, states that cardiovascular diseases continue to be the top global cause of death, claiming an estimated 17.9 million lives annually. Therefore, the heightened incidence of cardiovascular diseases is contributing to the surge in the growth of the autotransfusion device market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10275&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Autotransfusion Devices Market?
Leading firms in the autotransfusion devices sector are concentrating their efforts on the creation of technologically superior solutions such as next-generation intelligent control software. This technology aims to improve precision, efficiency and patient results during blood transfusions. The software is essentially composed of advanced algorithms that offer real-time optimization of blood recovery, processing and reinfusion, thus enhancing safety and efficiency for patients. For example, in March 2023, Haemonetics Corporation, a company based in the United States that provides blood and plasma supplies and services, revealed that the U.S. Food and Drug Administration (FDA) had granted clearance for their Cell Saver Elite+ Autotransfusion System. This next-gen software significantly improves the recovery of red blood cells during surgeries likely to result in medium to high blood loss. The groundbreaking upgrade simplifies the process of autotransfusion, minimizes unnecessary allogeneic transfusions and ultimately enhances patient outcomes.

What Are the Emerging Segments in the Autotransfusion Devices Market?
The autotransfusion devices market covered in this report is segmented -

1) By Product Type: Autotransfusion Systems, Consumables And Accessories
2) By Application: Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics And Gynecology Surgeries, Other Applications
3) By End-Use: Hospitals, Specialty Clinics, Other End Users

Subsegments:
1) By Autotransfusion Systems: Surgical Autotransfusion Systems, Emergency Autotransfusion Systems, Continuous Flow Autotransfusion Systems
2) By Consumables And Accessories: Collection Reservoirs, Blood Filters, Tubing Sets, Pumps, Anticoagulants

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10275&type=smp

Who Are the Global Leaders in the Autotransfusion Devices Market?
Major companies operating in the autotransfusion devices market include Becton dic*kinson And Company, Medtronic plc, LivaNova plc, Haemonetics Corporation, Fresenius SE & Co KGaA, Terumo Corporation, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, GE HealthCare Technologies Inc., Cerus Corporation, Stryker Corporation, Atrium Medical Technologies, Brightwake Ltd., Getinge AB, Beijing ZKSK Technology Co. Ltd., Braile Biomédica, Redax S.p.A., Teleflex Incorporated, Zimmer Biomet Holdings Inc., Gen World Medical Devices Corporation, Soma Technology International LLC, Beijing Jingjing Medical Equipment Co. Ltd., Johnson & Johnson Inc., Sorin Group, Baxter International Inc., Dideco, Nipro Corporation

Which are the Top Profitable Regional Markets for the Autotransfusion Devices Industry?
North America was the largest region in the autotransfusion devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global autotransfusion devices market during the forecast period. The regions covered in the autotransfusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10275

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.